SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-002362
Filing Date
2017-01-05
Accepted
2017-01-05 07:05:55
Documents
5
Period of Report
2017-01-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d264078d8k.htm 8-K 16176
2 EX-99.1 d264078dex991.htm EX-99.1 24323
3 GRAPHIC g264078g0105045638050.jpg GRAPHIC 2816
4 GRAPHIC g264078g0105045638160.jpg GRAPHIC 2838
5 GRAPHIC g264078g0105045638285.jpg GRAPHIC 2836
  Complete submission text file 0001193125-17-002362.txt   53920
Mailing Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 9TH FLOOR BOSTON MA 02109 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37471 | Film No.: 17508671
SIC: 8731 Services-Commercial Physical & Biological Research